Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
NCT03174951
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Pregnancy Loss
Interventions
DRUG:
IVIg
Sponsor
Tabriz University of Medical Sciences